Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > People selling taking profits today that bought in.17 to .22

<< Previous

Bullboard Posts

Next >>

Comment by KVDollarson Aug 23, 2021 3:36pm

169 Views

Post# 33749654

RE:RE:RE:RE:RE:People selling taking profits today that bought in.17 to .22

SamV21 wrote: Gap to fill at .275 see you there later in the week .Syqe has Teva and Tilray backing them if Tetra gets close to anything they will buy them for nothing because at that point Tetra will be broke and throw their military looking inhaler in the garbage .

You can clearly tell how much of a basher Sam is LOL - I dont even need go look at chats to confirm if there is gap

Sam is just here trying to halt a run that he has no control of LOL pathetic bunch of cocouuuu kaka

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1